GSK snaps up Argentine drugmaker for $253M

GlaxoSmithKline has acquired a leading Argentine pharma firm Laboratorios Phoenix for $253 million in a move to make further inroads into Latin America. Release | Report

Suggested Articles

Cell therapy manufacturing
Manufacturing

WuXi AppTec names Celgene veteran to CAR-T manufacturing lead

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

by Kyle Blankenship
Emergent Biosolutions
Manufacturing

Emergent, BARDA reach $628M contract to produce COVID-19 shots

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

by Kyle Blankenship
Gilead
Pharma

How much did Gilead's remdesivir help moderate COVID patients?

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.

by Angus Liu